Who Owns Enhabit Home Health & Hospice Company?

Enhabit Home Health & Hospice Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Enhabit Home Health & Hospice?

Understanding a company's ownership structure is crucial for investors and stakeholders alike. Enhabit Home Health & Hospice, a significant player in the healthcare sector, presents a compelling case study in ownership dynamics. From its origins to its current independent status, the evolution of Enhabit's ownership has shaped its strategic direction and market positioning.

This analysis will explore the journey of Enhabit, starting with its spin-off from Encompass Health Corporation in July 2022. We'll examine the key players in Enhabit ownership, including major shareholders and the impact of its public listing on the New York Stock Exchange under the ticker symbol 'EHAB'. For those seeking a deeper dive, consider a comprehensive Enhabit Home Health & Hospice SWOT Analysis to understand its strategic landscape. This exploration aims to provide a clear picture of who owns Enhabit Home Health & Hospice, a leading home health company and hospice provider.

The story of Enhabit Home Health & Hospice begins with Encompass Health Corporation's home health and hospice business. Enhabit's roots trace back to Encompass Home Health, Inc., established in Dallas, Texas, in 1998. While the specific founders and their initial equity in Encompass Home Health, Inc. aren't publicly detailed, the company expanded gradually.

Early growth included operations in Texas, Oklahoma, and New Mexico. Ownership changes marked significant milestones for the home health company. Enhabit's evolution reflects a series of acquisitions and strategic shifts within the healthcare sector.

In 2004, the founding management of Encompass Home Health sold a controlling stake to Apax Partners. This was followed by a recapitalization in 2007, with Thoma Cressey Bravo acquiring Apax Partner's interest. By 2014, Encompass Home Health had grown substantially.

Early Growth

Encompass Home Health, Inc. started in Dallas, Texas, in 1998. The company expanded its operations in Texas, Oklahoma, and New Mexico.

Ownership Changes

Apax Partners acquired a controlling stake in 2004. Thoma Cressey Bravo acquired Apax Partner's interest in 2007.

Company Size in 2014

By 2014, Encompass Home Health had 140 locations. It operated across 13 states with 5,000 employees.

Acquisition by HealthSouth

HealthSouth (later Encompass Health) acquired Encompass Home Health in 2014. The acquisition price was $750 million.

Market Position

Encompass Home Health was the fifth-largest provider of Medicare-focused, skilled home health services in the U.S. before the acquisition.

Enhabit's Emergence

Enhabit Home Health & Hospice emerged from Encompass Health Corporation's home health and hospice business.

Key Takeaways

The evolution of Enhabit Home Health & Hospice is marked by strategic acquisitions and ownership changes. The company's growth reflects the dynamic nature of the home health and hospice market.

• Encompass Home Health, Inc. was the foundation for Enhabit.
• Private equity firms played a significant role in early ownership.
• HealthSouth's acquisition in 2014 was a major milestone.
• The company's expansion included operations across multiple states.

Enhabit Home Health & Hospice SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The most significant shift in the ownership structure of Enhabit Home Health & Hospice occurred on July 1, 2022. This was when it spun off from Encompass Health Corporation (NYSE: EHC). This move established Enhabit as an independent, publicly traded entity. Its common stock began trading on the NYSE under the ticker symbol 'EHAB' on July 5, 2022. The spin-off involved a pro rata distribution. Encompass Health stockholders received one share of Enhabit common stock for every two shares of Encompass Health common stock they held as of June 24, 2022.

The spin-off was designed to be tax-free for U.S. federal income tax purposes for Encompass Health stockholders. This excludes any cash received in lieu of fractional shares. As a publicly traded company, Enhabit's ownership is now spread among various entities. These include institutional investors, mutual funds, index funds, and individual shareholders. The ownership structure is subject to change due to market activities. The company's revenue in 2023 was US$1.04 billion.

As a publicly traded entity, understanding the Target Market of Enhabit Home Health & Hospice is crucial. The company's operations and strategies are shaped by its ownership structure and the dynamics of the healthcare market.

Key Takeaways on Enhabit Ownership

Enhabit Home Health & Hospice is now an independent, publicly traded company.

• The spin-off from Encompass Health Corporation was a major event.
• Ownership is primarily held by institutional investors.
• The stock trades on the NYSE under the ticker symbol 'EHAB'.
• The company generated US$1.04 billion in revenue in 2023.

Enhabit Home Health & Hospice PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of early 2025, the Enhabit Home Health and Enhabit Hospice Board of Directors comprises nine members. The board includes individuals from various sectors, such as healthcare, technology, and finance. Jeffrey W. Bolton serves as the Chairman of the Board, a role he assumed on July 25, 2024. Barbara A. Jacobsmeyer, the President and CEO of Enhabit, is also a board member. Other members include Tina L. Brown-Stevenson, Charles M. Elson, Erin P. Hoeflinger, Stuart M. McGuigan, Gregory S. Rush, and Barry P. Schochet. Mark W. Ohlendorf, nominated by AREX Capital Management, was elected to the board in July 2024.

The board is focused on an orderly transition, with five members previously serving on the Encompass Health board gradually transitioning off over two years. Enhabit is actively recruiting additional candidates to ensure a balanced mix of skills and tenures. In February 2025, Enhabit announced the nomination of Stephan Rodgers, who has extensive experience in the home health and hospice industry, to stand for election at the 2025 annual meeting of stockholders.

The voting structure at Enhabit follows the standard one-share-one-vote model common in publicly traded companies. As of June 5, 2024, there were 50,156,310 shares of Enhabit common stock issued and outstanding. In 2024, Enhabit faced a proxy battle with AREX Capital Management, an activist investor holding 4.9% of the shares. AREX Capital sought to replace several board members. While stockholders elected eight of the company's director nominees, they also voted to elect AREX Capital's nominee, Mark W. Ohlendorf, reflecting the impact of activist investors.

Understanding Enhabit's Governance

Enhabit's board includes experienced members from diverse backgrounds, ensuring a range of perspectives. The company's voting structure is straightforward, with one vote per share. Recent events, such as the proxy battle with AREX Capital, highlight the influence of shareholders and the importance of corporate governance in the Enhabit ownership structure.

• The board consists of nine members.
• The Chairman of the Board is Jeffrey W. Bolton.
• The company faced a proxy battle in 2024.
• The company is publicly traded.

Enhabit Home Health & Hospice Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The recent history of Enhabit Home Health & Hospice, a prominent home health company and hospice provider, has been marked by significant shifts in its ownership structure. In July 2022, Enhabit completed a spin-off from Encompass Health, becoming an independent publicly traded entity. This move aimed to provide both entities with greater strategic and operational flexibility.

Following its independence, Enhabit initiated a strategic review in August 2023, considering options such as a merger or sale. This review was prompted by performance challenges, including labor pressures and the increasing penetration of Medicare Advantage (MA) plans. However, in May 2024, the board decided to remain independent, citing unfavorable macroeconomic conditions and a challenging healthcare operating environment that hindered viable transaction proposals. This decision led to a proxy fight with AREX Capital Management, an activist investor, who advocated for a sale of the company.

Financially, Enhabit reported a net loss of $46 million for Q4 2024, but anticipates net service revenue between $1.05 billion and $1.08 billion for the full year 2025. The company is focusing on growth strategies, including new payer contracts and cost-saving measures, such as branch closures. Enhabit's home health non-Medicare admissions increased by 10.7% year over year in Q4 2024, and hospice average daily census increased by 8.6% year over year in the same period. For more insights into the company's strategy, you can read more about the Growth Strategy of Enhabit Home Health & Hospice.

Ownership Changes

Enhabit transitioned from being a subsidiary to an independent publicly traded company, influencing its strategic direction and operational flexibility. This shift was a key development in the company's ownership profile.

Activist Investor Involvement

The involvement of AREX Capital Management, an activist investor, highlighted shareholder influence on the company's governance and strategic decisions. Their push for a sale underscores the importance of investor perspectives.

Financial Performance and Outlook

Despite a net loss in Q4 2024, Enhabit projects significant revenue for 2025 and is focusing on strategies to improve financial performance and growth, including new payer contracts and cost management.

Strategic Initiatives

Enhabit is implementing growth strategies, including new payer contracts and cost-saving measures. These initiatives are crucial for navigating the challenging healthcare environment and achieving its financial goals.

Enhabit Home Health & Hospice Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs